These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 36519944)
1. Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections. Lu KY; Wagner NJ; Velez AZ; Ceppe A; Conlon BP; Muhlebach MS Microbiol Spectr; 2023 Feb; 11(1):e0406122. PubMed ID: 36519944 [TBL] [Abstract][Full Text] [Related]
2. Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum. Britt NS; Hazlett DS; Horvat RT; Liesman RM; Steed ME Int J Antimicrob Agents; 2020 Apr; 55(4):105898. PubMed ID: 31931147 [TBL] [Abstract][Full Text] [Related]
3. The Virulence Potential of Livestock-Associated Methicillin-Resistant Treffon J; Fotiadis SA; van Alen S; Becker K; Kahl BC Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32486247 [No Abstract] [Full Text] [Related]
4. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections. Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701 [TBL] [Abstract][Full Text] [Related]
5. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant Park K-H; Kim D; Jung M; Kim DY; Lee Y-M; Lee MS; Hong K-W; Bae I-G; Hong SI; Cho O-H Microbiol Spectr; 2024 Jun; 12(6):e0341223. PubMed ID: 38651875 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis. Fusco NM; Toussaint KA; Prescott WA Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881 [TBL] [Abstract][Full Text] [Related]
7. Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients. Roch M; Varela MC; Taglialegna A; Rose WE; Rosato AE Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914961 [TBL] [Abstract][Full Text] [Related]
8. Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients. Suwantarat N; Rubin M; Bryan L; Tekle T; Boyle MP; Carroll KC; Jennings MT Diagn Microbiol Infect Dis; 2018 Apr; 90(4):296-299. PubMed ID: 29343421 [TBL] [Abstract][Full Text] [Related]
10. Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Seidl K; Chen L; Bayer AS; Hady WA; Kreiswirth BN; Xiong YQ Antimicrob Agents Chemother; 2011 Dec; 55(12):5631-9. PubMed ID: 21968365 [TBL] [Abstract][Full Text] [Related]
11. Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin. Fan YX; Chen MT; Li NY; Liu XF; Yang MJ; Chen YC; Liang XY; Wu JF; Guo BN; Song SC; Zhu YQ; Zhang FY; Hang JQ; Wu SB; Shen B; Li HY; Wang Q; Luo XM; Chen QG; Zhang HF; Wang RL; Shen LH; Fu FM; Song XL; Zhang J Microbiol Spectr; 2022 Oct; 10(5):e0134822. PubMed ID: 36094217 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. Champion EA; Miller MB; Popowitch EB; Hobbs MM; Saiman L; Muhlebach MS; Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686 [TBL] [Abstract][Full Text] [Related]
13. Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Dezube R; Jennings MT; Rykiel M; Diener-West M; Boyle MP; Chmiel JF; Dasenbrook EC J Cyst Fibros; 2019 May; 18(3):357-363. PubMed ID: 30131297 [TBL] [Abstract][Full Text] [Related]
14. Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial. Jennings MT; Boyle MP; Weaver D; Callahan KA; Dasenbrook EC Trials; 2014 Jun; 15():223. PubMed ID: 24925006 [TBL] [Abstract][Full Text] [Related]
15. Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study. Kappler M; Nagel F; Feilcke M; Kröner C; Pawlita I; Naehrig S; Ripper J; Hengst M; von Both U; Forstner M; Hector A; Griese M Pediatr Pulmonol; 2016 Oct; 51(10):1010-1019. PubMed ID: 27378061 [TBL] [Abstract][Full Text] [Related]
16. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434 [TBL] [Abstract][Full Text] [Related]
17. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran. Ghahremani M; Jazani NH; Sharifi Y J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049 [TBL] [Abstract][Full Text] [Related]
18. Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections. Butterfield JM; Tsuji BT; Brown J; Ashley ED; Hardy D; Brown K; Forrest A; Lodise TP Antimicrob Agents Chemother; 2011 Dec; 55(12):5433-7. PubMed ID: 21930887 [TBL] [Abstract][Full Text] [Related]
19. Quorum Sensing, Virulence, and Antibiotic Resistance of USA100 Methicillin-Resistant Staphylococcus aureus Isolates. Grundstad ML; Parlet CP; Kwiecinski JM; Kavanaugh JS; Crosby HA; Cho YS; Heilmann K; Diekema DJ; Horswill AR mSphere; 2019 Aug; 4(4):. PubMed ID: 31413175 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome. Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]